RGNX - REGENXBIO Inc.
IEX Last Trade
7.85
0.100 1.274%
Share volume: 32,174
Last Updated: Thu 26 Dec 2024 08:30:06 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$7.75
0.10
1.29%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-03 | 2023-02-28 | 2023-05-03 | 2023-08-02 | 2023-11-08 | 2024-02-27 | 2024-05-08 | 2024-08-01 | |
| Total revenue | 26.512 M | 31.345 M | 19.138 M | 19.977 M | 28.914 M | 22.213 M | 15.622 M | 22.295 M | |
| Cost of revenue | 13.323 M | 12.080 M | 4.112 M | 9.475 M | 12.388 M | 11.238 M | 4.283 M | 10.579 M | |
| Gross profit | 13.189 M | 19.265 M | 15.026 M | 10.502 M | 16.526 M | 10.975 M | 11.339 M | 11.716 M | |
| 46.07% | -22.00% | -30.11% | 57.36% | -33.59% | 3.32% | 3.32% | |||
| Operating expenses | 84.234 M | 83.715 M | 81.150 M | 83.584 M | 81.266 M | 74.760 M | 73.135 M | 67.724 M | |
| Selling general and admin | 20.921 M | 21.210 M | 22.634 M | 23.698 M | 23.083 M | 19.079 M | 18.291 M | 18.855 M | |
| Research and development | 63.313 M | 62.505 M | 58.516 M | 59.886 M | 58.183 M | 55.681 M | 54.844 M | 48.869 M | |
| Total expenses | 97.557 M | 89.116 M | 85.295 M | 93.085 M | 93.874 M | 86.116 M | 77.384 M | 78.332 M | |
| -8.65% | -4.29% | 9.13% | 0.85% | -8.26% | -10.14% | 1.23% | |||
| Operating income | -71.045 M | -57.771 M | -66.157 M | -73.108 M | -64.960 M | -63.903 M | -61.762 M | -56.037 M | |
| Ebit | -71.045 M | -57.771 M | -66.157 M | -73.108 M | -64.960 M | -63.903 M | -61.762 M | -56.037 M | |
| Pretax income | -75.484 M | -59.978 M | -66.676 M | -72.061 M | -61.868 M | -63.041 M | -63.330 M | -52.989 M | |
| -20.54% | 11.17% | 8.08% | -14.14% | 1.90% | 0.46% | -16.33% | |||
| Income tax | 0.000 | -43.000 K | 0.000 | 0.000 | 0.000 | -152.000 K | 0.000 | 0.000 | |
| Net income basic | -75.484 M | -59.935 M | -66.676 M | -72.061 M | -61.868 M | -62.889 M | -63.330 M | -52.989 M | |
| 20.60% | -11.25% | -8.08% | 14.14% | -1.65% | -0.70% | 16.33% | |||
| Net income | -75.484 M | -59.935 M | -66.676 M | -72.061 M | -61.868 M | -62.889 M | -63.330 M | -52.989 M | |
| 20.60% | -11.25% | -8.08% | 14.14% | -1.65% | -0.70% | 16.33% |